• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VERYAN MEDICAL LTD BIOMIMICS 3D VASCULAR STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VERYAN MEDICAL LTD BIOMIMICS 3D VASCULAR STENT SYSTEM Back to Search Results
Catalog Number 142122-06
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Stenosis (2263)
Event Date 07/11/2023
Event Type  Injury  
Event Description
The patient was treated as part of the mimics 3d usa post-market observational study.On (b)(6) 2022, the patient was implanted with one biomimics 3d (bm3d) stent in the left leg, a 6.0 x 80 mm stent which was used to treat a restenotic lesion of the superficial femoral artery (sfa) distal third to proximal popliteal artery.A contralateral approach was used and the lesion was prepared using pre-dilation with a percutaneous transluminal angioplasty (pta) balloon, atherectomy and cutting balloon.The treated segment was post-dilated with pta.The site identified an arterial stenosis (non-target, de-novo) event on 11-jul-23.It was reported as possibly related to the device and not related to the procedure.It was not target lesion related.The left tibioperoneal trunk (tpt) and posterior tibial artery were treated with pta/standard balloon angioplasty on 11-jul-23.The event was treated as part of an intervention on the sfa distal third to posterior tibial proximal third.This intervention also treated an occlusion of the bm3d stent identified on (b)(6) 2023 (mdr 3011632150-2023-00109) and a suspected stent fracture (mdr 3011632150-2023-00085) where a non-bm3d stent was placed.The intervention was reported as a target lesion/vessel revascularisation (tlr/tvr).The outcome was reported as resolved/recovered.The device remains implanted.
 
Manufacturer Narrative
There was no reported device malfunction and the device was not returned for analysis.A review has been performed of the manufacturing certificate of conformance associated with this lot.There were no non-conformances or deviations which could be associated with this event.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effect of worsening of peripheral arterial disease leading to additional surgical intervention, endovascular intervention or amputation is listed in the biomimics 3d instructions for use and is a known patient effect of peripheral stenting procedures.There is no indication of a product quality issue with respect to the design, manufacture or labelling of the device.If further information regarding this event becomes available, a follow-up report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOMIMICS 3D VASCULAR STENT SYSTEM
Type of Device
BIOMIMICS 3D VASCULAR STENT SYSTEM
Manufacturer (Section D)
VERYAN MEDICAL LTD
block 5
parkmore east business park
galway, H91 V 0TX
EI  H91 V0TX
Manufacturer Contact
alan mcdonagh
block 5
parkmore east business park
galway, H91 V-0TX
EI   H91 V0TX
MDR Report Key18495416
MDR Text Key332685495
Report Number3011632150-2023-00148
Device Sequence Number1
Product Code NIP
UDI-Device Identifier05391526850428
UDI-Public(01)05391526850428(17)230211(11)210713(10)0000096641
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 01/11/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/11/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/11/2023
Device Catalogue Number142122-06
Device Lot Number0000096641
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/14/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/13/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CLOPIDOGREL (PLAVIX)
Patient Outcome(s) Required Intervention;
Patient Age76 YR
Patient SexFemale
Patient Weight59 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-